Physician profile
James E Webb
NPI 1679561385
$2,601.52
in general payments reported to CMS, 2019-2025
16 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,647 · 2020: $22.95 · 2021: $171 · 2022: $74.30 · 2023: $172 · 2024: $147 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.37 |
| Education | $224.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $972.00 | 2019 | |
| Stryker Corporation | $431.79 | 2019-2023 | Augment Injectable |
| Djo, LLC | $224.00 | 2024-2025 | Dr Comfort |
| Spinefrontier, INC. | $187.17 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Smith+Nephew, INC. | $185.93 | 2019-2022 | |
| Zyla Life Sciences, INC. | $159.19 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Rikco International, LLC | $88.00 | 2019 | |
| Merck Sharp & Dohme LLC | $67.03 | 2019 | |
| Organogenesis INC. | $39.22 | 2022-2025 | Via Matrix |
| Nevro Corp. | $35.05 | 2024 | Senza |
| Depuy Synthes Sales INC. | $33.62 | 2022 | |
| Horizon Therapeutics Plc | $23.27 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $22.01 | 2025 | Nuzyra |
| Amgen INC. | $18.24 | 2025 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.